Administer orally using the provided measuring cup or spoon to ensure accurate dosing. Do not exceed the recommended dosage. Can be taken with or without food.

Dextromethorphan acts centrally on the cough center in the medulla to elevate the cough threshold, thereby reducing the urge to cough. Phenylephrine acts as an alpha-adrenergic agonist, causing vasoconstriction in the nasal passages to reduce swelling and congestion.

• •Hypersensitivity to Dextromethorphan, Phenylephrine, or any other component of the syrup.
• •Patients currently taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy.
• •Severe hypertension or severe coronary artery disease.
• •Known severe hepatic or renal impairment.
• •Narrow-angle glaucoma, urinary retention, or prostatic hypertrophy.

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children. Do not refrigerate.

Symptoms of overdose may include severe drowsiness, dizziness, nausea, vomiting, blurred vision, ataxia, nystagmus, hallucinations, agitation, respiratory depression, and convulsions. In case of overdose, seek immediate medical attention. Treatment is symptomatic and supportive, including activated charcoal if ingestion was recent, and respiratory support if needed.

Pregnancy Category C. Studies in animals have shown adverse effects on the fetus, and there are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus. Consult a doctor. It is not recommended during lactation without medical advice, as active ingredients may pass into breast milk.